Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 401 to 450 of 1898

TitleReference numberPublishedLast updated
Social, emotional and mental wellbeing in primary and secondary educationNG223
MiraQ for assessing graft flow during coronary artery bypass graft surgeryMTG8
Teduglutide for treating short bowel syndromeTA804
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
Nerve graft for corneal denervationIPG729
Depression in adults: treatment and managementNG222
Type 2 diabetes in adults: managementNG28
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
Multiple sclerosis in adults: managementNG220
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797
Reducing sexually transmitted infectionsNG221
Preterm labour and birthNG25
Gout: diagnosis and managementNG219
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Diroximel fumarate for treating relapsing–remitting multiple sclerosisTA794
Ibrutinib for treating Waldenstrom's macroglobulinaemiaTA795
Peristeen Plus transanal irrigation system for managing bowel dysfunctionMTG36
Thopaz+ portable digital system for managing chest drainsMTG37
Filgotinib for treating moderately to severely active ulcerative colitisTA792
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)IPG727
Social work with adults experiencing complex needsNG216
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Romosozumab for treating severe osteoporosisTA791
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisIPG726
Sleepio to treat insomnia and insomnia symptomsMTG70
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeIPG724
Vaccine uptake in the general populationNG218
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Liposuction for chronic lymphoedemaIPG723
Epilepsies in children, young people and adultsNG217
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781

Results per page

  1. 10
  2. 25
  3. 50
  4. All